Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients
Hélène C.F. Côté, Ph.D., Zabrina L. Brumme, B.S., Kevin J.P. Craib, M.Math., Christopher S. Alexander, Ph.D., Brian Wynhoven, B.S., Lillian Ting, B.S., Hubert Wong, Ph.D., Marianne Harris, M.D., P. Richard Harrigan, Ph.D., Michael V. O'Shaughnessy, Ph.D., and Julio S.G. Montaner, M.D.
Background Nucleoside analogues can induce toxic effects onmitochondria by inhibiting the human DNA polymerase . The toxiceffects can range from increased serum lactate levels to potentiallyfatal lactic acidosis. We studied changes in mitochondrial DNArelative to nuclear DNA in the peripheral-blood cells of patientswith symptomatic, nucleoside-induced hyperlactatemia.
Methods Total DNA was extracted from blood cells. A nucleargene and a mitochondrial gene were quantified by real-time polymerasechain reaction. Three groups were studied: 24 controls not infectedwith the human immunodeficiency virus (HIV), 47 HIV-infectedasymptomatic patients who had never been treated with antiretroviraldrugs, and 8 HIV-infected patients who were receiving antiretroviraldrugs and had symptomatic hyperlactatemia. The patients in thelast group were studied longitudinally before, during, and afterantiretroviral therapy.
Results Symptomatic hyperlactatemia was associated with markedreductions in the ratios of mitochondrial to nuclear DNA, which,during therapy, averaged 68 percent lower than those of non–HIV-infectedcontrols and 43 percent lower than those of HIV-infected asymptomaticpatients never treated with antiretroviral drugs. After thediscontinuation of antiretroviral therapy, there was a statisticallysignificant increase in the ratio of mitochondrial to nuclearDNA (P=0.02). In the patients followed longitudinally, the declinein mitochondrial DNA preceded the increase in venous lactatelevels.
Conclusions Mitochondrial DNA levels are significantly decreasedin patients with symptomatic, nucleoside-related hyperlactatemia,an effect that resolves on the discontinuation of therapy.
Source Information
From the British Columbia Centre for Excellence in HIV/AIDS (H.C.F.C., Z.L.B., K.J.P.C., C.S.A., B.W., L.T., M.H., P.R.H., M.V.O., J.S.G.M.) and the Canadian HIV Trials Network (H.W.), University of British Columbia, St. Paul's Hospital, Providence Health Care, Vancouver, B.C., Canada.
Address reprint requests to Dr. Montaner at St. Paul's Hospital, 667-1081 Burrard St., Vancouver, BC V6Z 1Y6, Canada, or at jmontaner{at}hivnet.ubc.ca.
Mitochondrial DNA and Nucleoside Toxicity
Chariot P., Bourokba N., Brivet F., Rastegar D. A., Casademont J., Miró O, Cardellach F., Montaner J. S.G., Coté H. C.F., Harrigan P. R.
Extract |
Full Text |
PDF
N Engl J Med 2002;
347:216-218, Jul 18, 2002.
Correspondence
This article has been cited by other articles:
Stankov, M. V., Lucke, T., Das, A. M., Schmidt, R. E., Behrens, G. M. N.
(2010). Mitochondrial DNA Depletion and Respiratory Chain Activity in Primary Human Subcutaneous Adipocytes Treated with Nucleoside Analogue Reverse Transcriptase Inhibitors. Antimicrob. Agents Chemother.
54: 280-287
[Abstract][Full Text]
Aldrovandi, G. M., Chu, C., Shearer, W. T., Li, D., Walter, J., Thompson, B., McIntosh, K., Foca, M., Meyer, W. A. III, Ha, B. F., Rich, K. C., Moye, J. Jr
(2009). Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected Women. Pediatrics
124: e1189-e1197
[Abstract][Full Text]
Tebas, P., Zhang, J., Hafner, R., Tashima, K., Shevitz, A., Yarasheski, K., Berzins, B., Owens, S., Forand, J., Evans, S., Murphy, R.
(2009). Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. J Antimicrob Chemother
63: 998-1005
[Abstract][Full Text]
Saitoh, A., Haas, R. H., Naviaux, R. K., Salva, N. G., Wong, J. K., Spector, S. A.
(2008). Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondrial DNA and RNA in Human Skeletal Muscle Cells. Antimicrob. Agents Chemother.
52: 2825-2830
[Abstract][Full Text]
Peterson, S., Martins, C. R., Cofrancesco, J. Jr.
(2008). Lipodystrophy in the Patient with HIV: Social, Psychological, and Treatment Considerations. Aesthetic Surgery Journal
28: 443-451
[Abstract][Full Text]
Ananworanich, J., Nuesch, R., Cote, H. C. F., Kerr, S. J., Hill, A., Jupimai, T., Laopraynak, N., Saenawat, S., Ruxrungtham, K., Hirschel, B.
(2008). Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy. J Antimicrob Chemother
61: 1340-1343
[Abstract][Full Text]
Papp, E., Gadawski, I., Cote, H. C. F.
(2008). Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells. J Antimicrob Chemother
61: 1048-1052
[Abstract][Full Text]
Xu, Y., Johansson, M., Karlsson, A.
(2008). Human UMP-CMP Kinase 2, a Novel Nucleoside Monophosphate Kinase Localized in Mitochondria. J. Biol. Chem.
283: 1563-1571
[Abstract][Full Text]
Saitoh, A., Fenton, T., Alvero, C., Fletcher, C. V., Spector, S. A.
(2007). Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondria in Human Immunodeficiency Virus Type 1-Infected Children Receiving Highly Active Antiretroviral Therapy. Antimicrob. Agents Chemother.
51: 4236-4242
[Abstract][Full Text]
Klein, D. K., Pilegaard, H., Treebak, J. T., Jensen, T. E., Viollet, B., Schjerling, P., Wojtaszewski, J. F. P.
(2007). Lack of AMPK{alpha}2 enhances pyruvate dehydrogenase activity during exercise. Am. J. Physiol. Endocrinol. Metab.
293: E1242-E1249
[Abstract][Full Text]
Fleischman, A., Johnsen, S., Systrom, D. M., Hrovat, M., Farrar, C. T., Frontera, W., Fitch, K., Thomas, B. J., Torriani, M., Cote, H. C. F., Grinspoon, S. K.
(2007). Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am. J. Physiol. Endocrinol. Metab.
292: E1666-E1673
[Abstract][Full Text]
Cameron, D. W., Becker, S., King, M. S., da Silva, B., Klein, C., Tokimoto, D., Foit, C., Calhoun, D., Bernstein, B., Hanna, G. J.
(2007). Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. J Antimicrob Chemother
59: 957-963
[Abstract][Full Text]
Chen, J., Kadlubar, F. F., Chen, J. Z.
(2007). DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair. Nucleic Acids Res
0: gkm010v2-12
[Abstract][Full Text]
Heyland, D. K., Dhaliwalm, R., Day, A., Drover, J., Cote, H., Wischmeyer, P.
(2007). Optimizing the Dose of Glutamine Dipeptides and Antioxidants in Critically Ill Patients: A Phase I Dose-Finding Study. JPEN J Parenter Enteral Nutr
31: 109-118
[Abstract][Full Text]
Drain, P. K, Kupka, R., Mugusi, F., Fawzi, W. W
(2007). Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am. J. Clin. Nutr.
85: 333-345
[Abstract][Full Text]
Timmermans, E. C., Tebas, P., Ruiter, J. P.N., Wanders, R. J.A., de Ronde, A., de Baar, M. P.
(2006). Real-Time Nucleic Acid Sequence-Based Amplification Assay to Quantify Changes in Mitochondrial DNA Concentrations in Cell Cultures and Blood Cells from HIV-Infected Patients Receiving Antiviral Therapy. Clin. Chem.
52: 979-987
[Abstract][Full Text]
Feola, D. J., Garvy, B. A.
(2006). Combination Exposure to Zidovudine plus Sulfamethoxazole-Trimethoprim Diminishes B-Lymphocyte Immune Responses to Pneumocystis murina Infection in Healthy Mice. CVI
13: 193-201
[Abstract][Full Text]
Masayesva, B. G., Mambo, E., Taylor, R. J., Goloubeva, O. G., Zhou, S., Cohen, Y., Minhas, K., Koch, W., Sciubba, J., Alberg, A. J., Sidransky, D., Califano, J.
(2006). Mitochondrial DNA Content Increase in Response to Cigarette Smoking. Cancer Epidemiol. Biomarkers Prev.
15: 19-24
[Abstract][Full Text]
Fall, P. J., Szerlip, H. M.
(2005). Lactic Acidosis: From Sour Milk to Septic Shock. J Intensive Care Med
20: 255-271
[Abstract]
Milazzo, L., Piazza, M., Sangaletti, O., Gatti, N., Cappelletti, A., Adorni, F., Antinori, S., Galli, M., Moroni, M., Riva, A.
(2005). [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother
55: 84-89
[Abstract][Full Text]
Kim, M. M., Clinger, J. D., Masayesva, B. G., Ha, P. K., Zahurak, M. L., Westra, W. H., Califano, J. A.
(2004). Mitochondrial DNA Quantity Increases with Histopathologic Grade in Premalignant and Malignant Head and Neck Lesions. Clin. Cancer Res.
10: 8512-8515
[Abstract][Full Text]
Noguera, A., Fortuny, C., Munoz-Almagro, C., Sanchez, E., Vilaseca, M. A., Artuch, R., Pou, J., Jimenez, R.
(2004). Hyperlactatemia in Human Immunodeficiency Virus-Uninfected Infants Who Are Exposed to Antiretrovirals. Pediatrics
114: e598-e603
[Abstract][Full Text]
Janes, M. S., Hanson, B. J., Hill, D. M., Buller, G. M., Agnew, J. Y., Sherwood, S. W., Cox, W. G., Yamagata, K., Capaldi, R. A.
(2004). Rapid Analysis of Mitochondrial DNA Depletion by Fluorescence In Situ Hybridization and Immunocytochemistry: Potential Strategies for HIV Therapeutic Monitoring. J. Histochem. Cytochem.
52: 1011-1018
[Abstract][Full Text]
Shaefer, M. S
(2004). Abacavir/Lamivudine/Zidovudine Continues to Be a Valid and Useful Antiretroviral Regimen. The Annals of Pharmacotherapy
38: 1314-1316
[Full Text]
Bai, R.-K., Wong, L.-J. C.
(2004). Detection and Quantification of Heteroplasmic Mutant Mitochondrial DNA by Real-Time Amplification Refractory Mutation System Quantitative PCR Analysis: A Single-Step Approach. Clin. Chem.
50: 996-1001
[Abstract][Full Text]
Johnson, J. A., Albu, J. B., Engelson, E. S., Fried, S. K., Inada, Y., Ionescu, G., Kotler, D. P.
(2004). Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am. J. Physiol. Endocrinol. Metab.
286: E261-E271
[Abstract][Full Text]
Montessori, V., Press, N., Harris, M., Akagi, L., Montaner, J. S.G.
(2004). Adverse effects of antiretroviral therapy for HIV infection. CMAJ
170: 229-238
[Abstract][Full Text]
Shafer, R. W., Smeaton, L. M., Robbins, G. K., De Gruttola, V., Snyder, S. W., D'Aquila, R. T., Johnson, V. A., Morse, G. D., Nokta, M. A., Martinez, A. I., Gripshover, B. M., Kaul, P., Haubrich, R., Swingle, M., McCarty, S. D., Vella, S., Hirsch, M. S., Merigan, T. C., the AIDS Clinical Trials Group 384 Team,
(2003). Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection. NEJM
349: 2304-2315
[Abstract][Full Text]
Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., Montaner, J. S.G.
(2003). Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 x 109 cells/L. ANN INTERN MED
139: 810-816
[Abstract][Full Text]
Note, R., Maisonneuve, C., Letteron, P., Peytavin, G., Djouadi, F., Igoudjil, A., Guimont, M.-C., Biour, M., Pessayre, D., Fromenty, B.
(2003). Mitochondrial and Metabolic Effects of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in Mice Receiving One of Five Single- and Three Dual-NRTI Treatments. Antimicrob. Agents Chemother.
47: 3384-3392
[Abstract][Full Text]
Laghi, F., Tobin, M. J.
(2003). Disorders of the Respiratory Muscles. Am. J. Respir. Crit. Care Med.
168: 10-48
[Abstract][Full Text]
Marceau, G., Sapin, V., Jacomet, C., Ughetto, S., Cormerais, L., Regagnon, C., Dastugue, B., Peigue-Lafeuille, H., Beytout, J., Laurichesse, H.
(2003). Frequency, Risk Factors, and Outcome of Hyperlactatemia in HIV-positive Persons: Implications for the Management of Treated Patients. Clin. Chem.
49: 1154-1162
[Abstract][Full Text]
Cherry, C. L., Wesselingh, S. L.
(2003). Nucleoside analogues and HIV: the combined cost to mitochondria. J Antimicrob Chemother
51: 1091-1093
[Full Text]
Chiu, R. W.K., Chan, L. Y.S., Lam, N. Y.L., Tsui, N. B.Y., Ng, E. K.O., Rainer, T. H., Lo, Y.M. D.
(2003). Quantitative Analysis of Circulating Mitochondrial DNA in Plasma. Clin. Chem.
49: 719-726
[Abstract][Full Text]
Antoniou, T., Weisdorf, T., Gough, K.
(2003). Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion. CMAJ
168: 195-198
[Abstract][Full Text]
Apodaca, A. A., Rakita, R. M.
(2003). Linezolid-Induced Lactic Acidosis. NEJM
348: 86-87
[Full Text]
Lewis, W.
(2003). Defective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol.
284: H1-H9
[Full Text]
Chariot, P., Bourokba, N., Monnet, I., Gherardi, R.
(2002). Hyperlactatemia and Human Immunodeficiency Virus Infection: Lessons from the Era of Antiretroviral Monotherapy. Antimicrob. Agents Chemother.
46: 3683-3683
[Full Text]
Madamanchi, N. R., Patterson, C., Runge, M. S.
(2002). HIV Therapies and Atherosclerosis: Answers or Questions?. Arterioscler. Thromb. Vasc. Bio.
22: 1758-1760
[Full Text]
Chariot, P., Bourokba, N., Brivet, F., Rastegar, D. A., Casademont, J., Miro, OÒs., Cardellach, F., Montaner, J. S.G., Cote, H. C.F., Harrigan, P. R.
(2002). Mitochondrial DNA and Nucleoside Toxicity. NEJM
347: 216-218
[Full Text]
(2002). A Novel Test for Mitochondrial Toxicity. AIDS Clin Care
2002: 6-6
[Full Text]
. The toxic effects can range from increased serum lactate levels to potentially fatal lactic acidosis. We studied changes in mitochondrial DNA relative to nuclear DNA in the peripheral-blood cells of patients with symptomatic, nucleoside-induced hyperlactatemia. 
Previous
